SAN DIEGO, Jan. 18, 2018 -- IntelliGuard, developer of Intelligent Inventory Solutions™ for critical inventory management in healthcare, today announced a Purchase and License Contract to implement its Vendor Managed Inventory System™ to support the QIAGEN QIAstock Inventory Program.
QIAGEN manufactures more than 500 core products and serves more than 500,000 customers around the globe with solutions for molecular testing. Their Sample to Insight® solutions serve four major customer categories. The QIAstock Inventory Program, powered by IntelliGuard, will initially focus on Academia and Pharma.
The QIAstock Inventory Program provides an efficient and economical way to make QIAGEN products available at customer sites when and where researchers need them. QIAGEN representatives work with customers to decide which QIAGEN products will be available in each QIAstock location. These products are then provided by QIAGEN as an onsite supply stored in IntelliGuard® RFID-enabled Smart Cabinets™ for immediate access and use by researchers.
Using advanced RFID technology along with an integrated hardware and software platform, IntelliGuard® cabinets automatically transmit inventory levels to QIAGEN as product is removed or restocked. QIAGEN representatives remotely monitor inventory, track products as they are used and replenish stock based on an agreed-upon replenishment schedule. The IntelliGuard® Vendor Managed Inventory System™ offers cold, controlled room temperature and ambient storage cabinets in numerous sizes to support the safe storage and on-site stocking needs of a variety of inventory.
“QIAGEN is an ideal partner for the IntelliGuard® Vendor Managed Inventory System™,” said Gordon Krass, IntelliGuard CEO. “As a global company with hundreds of QIAstock locations operating throughout the world, we are excited to help QIAGEN continue to deliver the high-quality customer service they are known for, while increasing revenue, maximizing inventory visibility and improving operational efficiency.”
This contract follows a successful trial of the QIAstock Inventory Program, powered by the IntelliGuard® RFID Platform at several U.S. customer locations and provides for expansion throughout North America and Europe.
About IntelliGuard® Intelligent Inventory Solutions™
IntelliGuard (http://ig.solutions) is a leading innovator of Radio Frequency Identification (RFID) solutions that offer automation to enable effective and efficient management of pharmaceutical inventory and critical care supplies in healthcare. IntelliGuard® Intelligent Inventory Solutions™ provide unparalleled automation, real-time visibility, data and intelligence that touch nearly every part of the supply chain distribution process – from hospital and health system pharmacies to manufacturer and distributor supply chains. We develop and patent technology and processes with an unwavering commitment to accuracy to eliminate human error, improve cost control, reduce risk, and increase efficiency. IntelliGuard® Solutions include the following modular, scalable inventory management systems: Kit and Tray Management System, Linked Visibility Inventory System™, Smart Cabinet Inventory System and Vendor Managed Inventory System. IntelliGuard is a charter member of RAIN RFID global alliance.
IntelliGuard is a dba of MEPS Real-Time, Inc. MEPS, MEPS Real-Time and IntelliGuard are registered trademarks and Intelligent Inventory Solutions, IG Solutions and the IG logo are trademarks of MEPS Real-Time, Inc., Carlsbad, CA, in the United States and/or other countries.
QIAGEN is a registered trademark of the QIAGEN Group.
Contact: Angela Smoley Phone: 760.448.9500 Email: [email protected]


Baidu Approves $5 Billion Share Buyback and Plans First-Ever Dividend in 2026
Global PC Makers Eye Chinese Memory Chip Suppliers Amid Ongoing Supply Crunch
Toyota’s Surprise CEO Change Signals Strategic Shift Amid Global Auto Turmoil
Trump Backs Nexstar–Tegna Merger Amid Shifting U.S. Media Landscape
Uber Ordered to Pay $8.5 Million in Bellwether Sexual Assault Lawsuit
Hims & Hers Halts Compounded Semaglutide Pill After FDA Warning
SoftBank Shares Slide After Arm Earnings Miss Fuels Tech Stock Sell-Off
Instagram Outage Disrupts Thousands of U.S. Users
Missouri Judge Dismisses Lawsuit Challenging Starbucks’ Diversity and Inclusion Policies
Tencent Shares Slide After WeChat Restricts YuanBao AI Promotional Links
Nasdaq Proposes Fast-Track Rule to Accelerate Index Inclusion for Major New Listings
Prudential Financial Reports Higher Q4 Profit on Strong Underwriting and Investment Gains
OpenAI Expands Enterprise AI Strategy With Major Hiring Push Ahead of New Business Offering
Sony Q3 Profit Jumps on Gaming and Image Sensors, Full-Year Outlook Raised
Nvidia, ByteDance, and the U.S.-China AI Chip Standoff Over H200 Exports
Once Upon a Farm Raises Nearly $198 Million in IPO, Valued at Over $724 Million
American Airlines CEO to Meet Pilots Union Amid Storm Response and Financial Concerns 



